Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phototherapy Combination With Topicals in Vitiligo
Sponsor: Jordan University of Science and Technology
Summary
Patients will be included in a randomized controlled clinical trial, will enroll only adult vitiligo patients with surface area of at least 10% who are being followed in the outpatient dermatology clinics of King Abdullah University Hospital (KAUH) and are planned to start on phototherapy Narrow Band Ultraviolet light B (NBUVB), regardless if they have previous treatment for their disease, one month wash off period will be given for patients who are already on phototherapy or other treatments for vitiligo.
Official title: Comparison of the Efficacy of Tacrolimus 0.1% Ointment vs Calcipotriol/Betamethasone in Combination With NBUVB in Treatment of Vitiligo
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
41
Start Date
2020-06-21
Completion Date
2023-03-30
Last Updated
2026-10-27
Healthy Volunteers
No
Conditions
Interventions
Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly
Tacrolimus ointment plus phototherapy NBUVB (Tacrolimus arm)
Calcipotriol/Betamethasone ointment plus NBUVB
Calcipotriol/Betamethasone ointment once daily plus NBUVB 3 times weekly
Locations (1)
Diala Alshiyab
Irbid, Jordan